CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $55,908,861 | +66.0% | 1,455,202 | 0.0% | 0.32% | +77.0% |
| Q1 2023 | $33,687,926 | -49.3% | 1,455,202 | -42.6% | 0.18% | -54.1% |
| Q4 2022 | $66,393,472 | +33.3% | 2,534,102 | 0.0% | 0.40% | +22.4% |
| Q3 2022 | $49,820,000 | +12.4% | 2,534,102 | 0.0% | 0.33% | +29.9% |
| Q2 2022 | $44,321,000 | +16.1% | 2,534,102 | +8.6% | 0.25% | +14.6% |
| Q1 2022 | $38,186,000 | +0.3% | 2,334,102 | 0.0% | 0.22% | +18.4% |
| Q4 2021 | $38,069,000 | +56.8% | 2,334,102 | +22.6% | 0.18% | +72.9% |
| Q3 2021 | $24,283,000 | +59.2% | 1,903,069 | +76.1% | 0.11% | +59.7% |
| Q2 2021 | $15,255,000 | +31.1% | 1,080,393 | +44.3% | 0.07% | +34.0% |
| Q1 2021 | $11,635,000 | -2.0% | 748,693 | 0.0% | 0.05% | +11.1% |
| Q4 2020 | $11,874,000 | – | 748,693 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 3,168,388 | $49,237,000 | 9.08% |
| ATP Life Science Ventures, L.P. | 4,028,937 | $62,610,000 | 6.97% |
| Affinity Asset Advisors, LLC | 175,000 | $2,720,000 | 0.92% |
| Altium Capital Management LP | 205,799 | $3,198,000 | 0.89% |
| EcoR1 Capital, LLC | 1,250,001 | $19,425,000 | 0.86% |
| Vivo Capital, LLC | 1,206,266 | $18,745,000 | 0.66% |
| Rubric Capital Management LP | 325,863 | $5,064,000 | 0.30% |
| Rock Springs Capital Management LP | 673,049 | $10,459,000 | 0.23% |
| Orbimed Advisors | 1,250,001 | $19,425,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 549,615 | $8,541,000 | 0.13% |